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The National COVID Cohort Collaborative (N3C):  N3C is an NIH NCATS-sponsored 
analytics platform that contains clinical data from the electronic health records of people who 
were tested for the novel coronavirus or who have had related symptoms. 
UMass Medical School was one of the first 12 vanguard sites to deposit COVID data to N3C. 
We are happy to announce that we have executed all the regulatory work required to facilitate 
access to N3C Data Enclave for our UMMS and Memorial investigators. 
 
CTSA sites across the country are continuing to contribute data to N3C with the goal of 
creating a harmonized data set from all 60+ CTSA’s. Currently, the N3C Data Enclave boasts 
upwards of 600K COVID related cohorts (>60K COVID positive data) from 15 sites. Access to 
de-identified or identified data sets is available: a) access to de-identified or safe harbor 
datasets does not require institutional IRB approval; and b) access to datasets with PHI 
requires institutional IRB approval. More information on the N3C Data Enclave is available at 
https://ncats.nih.gov/n3c. For any questions or assistance in gaining access to N3C Data 




UMass Integrative Biomarker Center (InBioC) open for business: At the UMass 
Integrative Biomarker Center (InBioC), we look forward to working with investigators to 
provide relevant and timely proteomics or RNA measurements (i.e. microRNA, mRNA, etc) to 
support clinical projects for validation, preliminary data, grant submissions, etc.  We do 
require that data generated as part of this initiative be made available to other investigators 
as part of a virtual data repository that will allow data sharing and/or reanalysis.    
We will provide “Seed Money” along with support for investigators to generate data needed 
for programs, grants, and projects. Initially, these will be awarded in the range of 1-5K.  
Please see our webpage (https://www.umassmed.edu/InBioC/) to learn more. 
 
COVID-19 
Clinical Research Nurses Needed for RADx Studies: The Center for Advancing Point of 
Care Therapeutics (CAPCaT) has been designated as a national test center for the NIH 
Rapid Acceleration of Diagnostics (RADx) program. Our Center is looking for experienced 
clinical research nurses with an interest in working with people undergoing COVID-19 testing 
to collect information and specimens in order to validate new and innovative test devices 
coming to UMass from around the world. The positions are available immediately. If you are 
interested or if you have any questions, please contact Danielle Howard 
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(Danielle.howard@umassmed.edu) or apply at 
https://www.ummsjobs.com/job/5416/  or  https://www.ummsjobs.com/job/5000/ 
 
UMMS UPDATE regarding human subjects research during the COVID-19 pandemic can be 
found here: https://umassmed.edu/ccts/covid-19/. This website is updated frequently; last 
update Nov 12, 2020. 
 
NIH UPDATE: For up-to-date NIH COVID-19 information, including informational videos, 
proposal submission and award management resources, human subjects and clinical trials 
guidance, animal welfare, frequently asked questions regarding flexibilities for grantees, and 
funding opportunities, click here: https://www.nih.gov/health-information/coronavirus  
 
CLINICAL TRIALS DATABASE: To search for active Covid-19 clinical trials at UMMS, 
please visit https://www.conqueringdiseases.org/ . Conquering Diseases is an easy to use 
web-based search tool to find, share and save clinical studies relevant to patients. It also 
provides educational resources to help patients and families learn about and find clinical 
studies. It provides a patient-friendly and direct way to learn about clinical studies and a 
secure environment to share clinical study opportunities and communicate with study staff for 
screening and enrollment into clinical studies. 
THE NATIONAL COVID COHORT COLLABORATIVE (N3C): The National COVID Cohort 
Collaborative (N3C) Data Enclave is now open to scientists looking for evidence-based 
answers to COVID-19 research questions. This centralized and secure national data 
analytics platform is for COVID-19 research, including studying potential risk factors, 
protective factors and long-term health consequences, as the pandemic continues to evolve. 
Its data and analytics capabilities will grow over time. Learn more about the N3C data and 
applying for access. 
EVENTS 
Community Engagement and Collaboration Core Fall 2020 Webinar Series: Panelists 
will describe and present findings on three studies completed and in process to reduce the 
health risks for justice-involved persons in Massachusetts.  
Title: Strategies for reducing adverse outcomes for criminal justice-involved populations 
Time: November 16, 2020, 11:00 AM – 12:00 PM 
Registration link: https://arcsapps.umassmed.edu/redcap/surveys/?s=RK7NH9K934  
 
Assay Guidance Workshop for High-Throughput Screening and Lead Discovery: 
NCATS is hosting a two-day workshop that will cover a broad range of critical concepts 
underlying assay development and implementation for high-throughput screening and lead 
discovery projects. This workshop is designed to disseminate critical information about the 
implementation of robust assay methods and is particularly relevant for researchers 
developing molecular probes or clinical candidates.  
Time: Nov 18 8:30 – 5:30 and 19 8:50 – 5:00.   
Registration link: https://ncats.corsizio.com/c/5c7d654ab7541f6fabbbcb35  
 
2020 NIH Rural Health Seminar: Challenges in the Era of COVID-19: Join NCATS and the 
National Institute on Minority Health and Health Disparities for the 2020 NIH Rural Health 
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Seminar: Challenges in the Era of COVID-19. The seminar will bring together researchers, 
medical practitioners and others to explore topics in rural health. Learn about the impact of 
COVID-19 on rural populations, on systems and workforce issues, and on community 
engagement in response to the pandemic.  
Time: November 19, 2020, 1:00 – 5:00 PM.   
Registration link:  https://www.eventbrite.com/e/2020-nih-rural-health-seminar-challenges-in-
the-era-of-covid-19-tickets-117521105791  
 
Virtual Workshop on Systemic Immunogenicity Considerations for AAV-Mediated Gene 
Therapy: The National Center for Advancing Translational Sciences (NCATS) at the National 
Institutes of Health (NIH) and the Center for Biologics Evaluation and Research (CBER) at 
the U.S. Food and Drug Administration (FDA) are co-hosting a virtual Workshop on Systemic 
Immunogenicity Considerations for Adeno-Associated Virus (AAV)-Mediated Gene Therapy. 
This meeting will bring together scientists, therapeutic developers and patient representatives 
to focus on immunogenicity issues related to the systemic administration of AAV gene 
therapy products and identify solutions for those issues.  
Nov. 30 – Dec. 1, 2020 
Click here to register: https://events-
support.com/events/NCATS_Gene_Therapies_November_2020  
 
Intersections Science Fellows Symposium: The main goals of this cross-institutional 
symposium are to showcase the outstanding research of postdocs in the biological sciences, 
including those from backgrounds historically underrepresented in academia, and to support 
the scientific and professional development of the next generation of academic faculty. For 
more details, see the symposium website: https://www.intersectionssciencefellows.com/  
January 6-8, 2021 
 
FUNDING 
CCTS SPARK PROGRAM: Rolling application deadline.  This program’s priorities are to 
support studies that impact clinical care and research methodologies, support 
students/trainees, and provide access to funds to generate pilot and preliminary data for 
external grant submissions.  For more information, click on this link: 
https://www.umassmed.edu/ccts/funding/spark-program/ 
 
CCTS SMALL CONFERENCE GRANTS: Rolling application deadline.  This funding 
facilitates the development of faculty-to-faculty networks within the University system.  Click 
on this link for more information: https://umassmed.edu/ccts/funding/small-conference-grants/ 
FUNDING OPPORTUNITY: postdoctoral fellowships to prepare the next generation of 
scientists to conduct implementation research that addresses critical cancer prevention and 
control care delivery issues. 
 
NCATS ASPIRE: Reduction-to-Practice Challenge: Opens 11/30.  NCATS invites innovators 
and multi-expert teams to participate in the NCATS ASPIRE Reduction-to-Practice 
Challenge. The goal is the development of a platform that scientists can use to advance their 
translational science relevant to development and testing of new and safer treatments of 
pain, opioid use disorder and overdose. NCATS anticipates that this integrated platform 
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ultimately can be generalized to address many of the roadblocks in automated chemistry. 
Stage 1 of the Reduction-to-Practice Challenge opens Nov. 30, 2020, and submissions are 




Postdoctoral Training in Cancer Prevention and Control: The NCI-funded PRACCTIS 
program (Prevention and Control of Cancer: Training for Change in Individuals and Systems) 
at UMMS is now accepting applications for postdoctoral scholars to start January 2021 and 
August 2021. We train independent researchers to address critical prevention and control 
care delivery issues across the cancer continuum, including primary prevention, screening, 
diagnosis, treatment and survivorship, with emphasis on promoting change in individuals, 
providers and systems. Our faculty mentors are leaders in implementation science, health 
equity and low resource settings, health behavior change, health informatics, systems 
change and health policy, health communications, population health sciences, and prevention 
and intervention research. Applicants must plan to pursue an independent research career 
focused on cancer prevention and control, have earned a doctoral degree (PhD, ScD, MD, 
DO, etc.), and be a U.S. citizen or permanent resident. For more information contact Barbara 
Estabrook, Barbara.estabrook@umasmed.edu 
GREATER WORCESTER COVID-19 COMMUNITY HEALTH SURVEY: UMass Medical 
School, in collaboration with the City of Worcester and the Central Massachusetts Regional 
Public Health Alliance is conducting the Great Worcester COVID-19 Community Health 
Survey.  The online survey, which takes about 10 minutes to complete, asks respondents 
about changes in their lives due to COVID since March 10, including their health, finances, 
activities outside the home, access to medical care, employment, housing and food security. 
The names of the street a respondent lives on and the closest cross street will be vital for 
understanding circumstances in specific neighborhoods. Providing contact information is 
optional for respondents who want to receive survey results, and who are willing to be 
contacted about the survey. The survey also provides a list of local resources for households 
experiencing distress due to COVID-19. The survey is available in English, Spanish, 
Portuguese, Vietnamese, Albanian and Russian. To participate, please click here. 
DID YOU KNOW? 
HRPP QA/QI: The Human Research Protection Program (HRPP) Quality Assurance/Quality 
Improvement (QA/QI) Program is a component of the UMass Center for Clinical and 
Translational Science. The program is independent of the IRB and helps study teams and 
investigators by conducting routine post-approval monitoring of on-going research to evaluate 
adherence with institutional requirements and federal regulations. If there are review findings, 
the QA/QI manager shares those findings with investigators and study teams, and provides 
direct education on the findings, including how to avoid making similar errors in the future. In 
order to support improvement at an institutional level, the QA/QI manager shares aggregated 
data from reviews with the HRPP leadership and the Research Community to identify trends 
and target areas for education. The program also makes self-evaluation tools available to 
investigators and study teams seeking to perform their own assessments.  To learn more 
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about HRPP QA/QI HRP-142, visit: https://www.umassmed.edu/globalassets/ccts/ccts-
media/irb/updated-sops-2015/hrp-142-hrpp-qa-qi-program-final.pdf. 
 
NATIONAL CENTER FOR DATA TO HEALTH (CD2H): The goal of CD2H is to make data 
more meaningful, open and accessible. The CD2H supports a vibrant and evolving 
collaborative informative ecosystem for the CTSA program and beyond. The CD2H 
harnesses and expands an ecosystem for translational scientists to discover and share their 
software, data and other research resources within the CTSA program network.  The CD2H 
also creates a social coding environment for translational science institutions, leveraging the 
community-driven DREAM challenges as a mechanism to stimulate innovation. To learn 
more, click here. 
 
SHARE YOUR SUCCESS STORY 
Have you had your research published that cites the UMass Center for Clinical and 
Translational Science?  Has your patent been filed on technology developed using Center 
funding or resources? Did your pilot project receive external grant funding? Share it with us at 
ccts@umassmed.edu. Sharing your success demonstrates the importance and effect of the 
Center for Clinical and Translational Science at UMass. 
 
 
CITE & SUBMIT 
Please cite the NIH CTSA award any time you use The UMMS Center for Clinical and 
Translational Science resources, services and facilities or received funding through the 
Center. “The project described is supported by the National Center for Advancing 
Translational Sciences, National Institutes of Health, through Grant UL1 TR001453, (or 
TL1 TR001454, or KL2 TR001455, as appropriate). The content is solely the 
responsibility of the authors and does not necessarily represent the official views of 
the NIH.”  
 
Newsletter Submissions: To be included in the CCTS Monthly Newsletter, please send 
announcements, including a link, to ccts@umassmed.edu. The newsletter is published the 
first week of each month. 
 
University of Massachusetts Center for Clinical and Translational Science, 55 Lake Avenue N, Worcester MA 
01655 
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